학술논문

Chemoprevention in African American men with prostate cancer: the underlying biology of carcinogenesis should be addressed in African American men at high risk for prostate cancer
Document Type
Report
Source
Cancer Control. October 1, 2016, p415, 9 p.
Subject
Prostate cancer -- Prevention
Chemotherapy -- Methods -- Patient outcomes
Cancer -- Chemotherapy
African Americans -- Health aspects
Language
English
ISSN
1073-2748
Abstract
Background: Recommendations for cancer screening are uncertain for the early detection or prevention of prostate cancer in African American men. Thus, chemoprevention strategies are needed to specifically target African American men. Methods: The evidence was examined on the biological etiology of disparities in African Americans related to prostate cancer. Possible chemopreventive agents and biomarkers critical to prostate cancer in African American men were also studied. Results: High-grade prostatic intraepithelial neoplasia may be more prevalent in African American men, even after controlling for age, prostate-specific antigen (PSA) level, abnormal results on digital rectal examination, and prostate volume. Prostate cancer in African American men can lead to the overexpression of signaling receptors that may mediate increased proliferation, angiogenesis, and decreased apoptosis. Use of chemopreventive agents may be useful for select populations of men. Conclusions: Green tea catechins are able to target multiple pathways to address the underlying biology of prostate carcinogenesis in African American men, so they may be ideal as a chemoprevention agent in these men diagnosed with high-grade prostatic intraepithelial neoplasia.
Introduction Despite treatment advances in recent years, prostate cancer remains the leading cause of cancer-related death among men in the United States. (1) In 2016, the American Cancer Society estimates [...]